Stocktoria
Insight Molecular Diagnostics Inc. IMDX
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 2015-12-30
Chart by TradingView
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $4.1M | $1.9M | $1.5M | $958,000 | $2.2M |
| Gross profit | $2.3M | $740,000 | $413,000 | -$18,000 | $1.4M |
| Operating income | -$51.1M | -$61.0M | -$25.1M | -$18.0M | -$53.7M |
| Net income | -$50.2M | -$60.7M | -$27.8M | -$72.9M | -$64.1M |
| Operating cash flow | -$22.2M | -$20.7M | -$23.3M | -$45.6M | -$35.9M |
| Free cash flow | -$25.4M | -$21.2M | -$23.6M | -$49.9M | -$38.2M |
| Total assets | $25.8M | $35.1M | $74.9M | $100.1M | $159.6M |
| Total liabilities | $57.2M | $47.4M | $49.3M | $60.5M | $94.3M |
| Shareholders' equity | -$31.5M | -$12.3M | $20.5M | $34.3M | $65.2M |
| Ratios | |||||
| Gross margin | 56.7% | 39.3% | 27.5% | -1.9% | 64.6% |
| Operating margin | -1260.8% | -3245.1% | -1672.4% | -1878.6% | -2444.3% |
| Net margin | -1238.5% | -3225.0% | -1848.4% | -7609.8% | -2916.2% |
| FCF margin | -625.6% | -1127.3% | -1570.6% | -5209.6% | -1737.4% |
| Return on assets | -195.0% | -172.9% | -37.1% | -72.8% | -40.2% |
| Return on equity | 159.6% | 494.2% | -135.7% | -212.6% | -98.3% |
| Current ratio | 1.27 | 1.62 | 1.49 | 2.11 | 2.77 |
| Revenue growth | 115.6% | 25.1% | 56.9% | -56.4% | 80.8% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 12,250 | $40,180 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001642380 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.